Which has grown faster, BAX or CORT?

Over the past five years, CORT grew revenue faster — BAX at a -1.22% CAGR versus CORT at 19.35%.

Does BAX or CORT pay a bigger dividend?

BAX pays a dividend (0.17% yield), while CORT has no payments in the available dividend history.

Is BAX or CORT more profitable?

CORT runs the higher net margin — BAX at -9.27% versus CORT at 6.61%.

How have BAX and CORT total returns compared?

Over the past 10 years, BAX delivered -5.15% and CORT delivered 33.70% annualized total return. Past performance doesn't predict future results.

Baxter International Inc. (BAX) vs Corcept Therapeutics Incorporated (CORT)

A side-by-side comparison of Baxter International Inc. and Corcept Therapeutics Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BAX

Baxter International Inc.

$12.52B

$24.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

CORT

Corcept Therapeutics Incorporated

$13.19B

$122.03HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BAX vs CORT

growth of $100 · dividends reinvested · last 10y

BAX -39.8% (-4.9%/yr)CORT +1754.6% (+33.9%/yr)CORT compounded faster over this window

Log scale — wide-divergence pair

BAX CORT

BAX vs CORT: by the numbers

•CORT is the larger company ($13.19B vs $12.52B market cap).
•CORT is profitable (6.61% net margin) while BAX runs a net loss (-9.27%).
•CORT grew revenue faster over the past five years (19.35% vs -1.22% CAGR).
•BAX pays a dividend (0.17% yield), while CORT has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BAX	CORT
P/E ratio	N/A	290.55
Forward P/E	11.79	N/A
P/S ratio	1.09	15.88
P/B ratio	2.02	18.69
EV / EBITDA	29.51	1483.24
FCF yield	5.41%	0.81%

Profitability

Metric	BAX	CORT
Gross margin	30.08%	98.30%
Operating margin	-2.39%	0.77%
Net margin	-9.27%	6.61%
ROE	-17.13%	7.78%
ROIC	-1.61%	0.87%

Dividends

Metric	BAX	CORT
Dividend yield	0.17%	N/A

Growth (annualized)

Metric	BAX	CORT
Revenue CAGR (5Y)	-1.22%	19.35%
EPS CAGR (5Y)	N/A	0.64%
FCF CAGR (5Y)	-12.92%	-4.40%
Total return CAGR (5Y)	-19.87%	43.90%

Frequently asked

Which has grown faster, BAX or CORT?: Over the past five years, CORT grew revenue faster — BAX at a -1.22% CAGR versus CORT at 19.35%.
Does BAX or CORT pay a bigger dividend?: BAX pays a dividend (0.17% yield), while CORT has no payments in the available dividend history.
Is BAX or CORT more profitable?: CORT runs the higher net margin — BAX at -9.27% versus CORT at 6.61%.
How have BAX and CORT total returns compared?: Over the past 10 years, BAX delivered -5.15% and CORT delivered 33.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BAX analysis Full CORT analysis Interactive comparison tool

Dig into the metrics

Corcept Therapeutics P/E ratio Baxter International dividend yield Baxter International ROE Corcept Therapeutics ROE Baxter International operating margin Corcept Therapeutics operating margin Baxter International revenue growth Corcept Therapeutics revenue growth Baxter International free cash flow Corcept Therapeutics free cash flow

Baxter International & Corcept Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.